- for speed listening, go to the settings wheel on the bottom right of the video and choose playback speed - after one minute video becomes high-resolution.

Intro and Cap Structure - 2 Jul 25

Company & Industry - 2 Jul 25

Model - 2 Jul 25

Legal & Ownership Structure - 2 Jul 25

Investment Discussion - 2 Jul 25
Our projections were broadly accurate, with revenue €7m higher and EBITDA €4m higher than reported. However, we continue to find
Please find our updated analysis on BioGroup here.
Given the spread widening during the Summer, we have re-visited the investment case for a long trade. The sub bonds are attractive, and given that
BioGroup shareholders have informally appointed Centerview Partners to explore options for an exit. This appears to be at the
The new format of HY conference calls, which gives preference to typed questions rather than live telephone inquiries, has resulted in
BioGroup released its Q2 results yesterday. However, with minimal commentary provided in the announcement and the earnings call not
One of the sources of the turmoil in French politics is the 2026 Budget and the debt reduction plans used to narrow France’s deficit from its current
BioGroup Live Discussion is now available on Biogroup’s page, here.
Please find our initiation on BioGroup here.
Many of you have asked us to look at BioGroup following our detailed analysis on Cerba. Although BioGroup operate and is subject to